CNS Pharmaceuticals Inc (CNSP)
NASDAQ
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -270.37 | -1749.586 | -90.215 | -79.596 | -114.067 | -140.064 | -255.537 |
Return on Equity (%) | 742.373 | 2431.579 | -109.955 | -87.781 | -136.471 | -207.035 | -1018.698 |
Return on Invested Capital (%) | 728.814 | 250.925 | -110.191 | -89.135 | -147.871 | -234.732 | -1211.625 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | -0.006 | -0.043 | 0.462 | 0.585 | 0.237 | 0.203 | -0.844 |
Earnings Per Share | -0.021 | -0.582 | -0.236 | -0.396 | -0.503 | -0.382 | -3.591 |
Cash Per Share | 0.011 | 0.022 | 0.44 | 0.588 | 0.179 | 0.251 | 0.105 |
Working Capital Per Share | -0.006 | -0.051 | 0.461 | 0.57 | 0.191 | 0.191 | -0.865 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.021 | -0.582 | -0.236 | -0.396 | -0.503 | -0.382 | -3.591 |
EBITDA Per Share | -0.021 | -0.582 | -0.236 | -0.396 | -0.503 | -0.382 | -3.591 |
Free Cash Flow Per Share | -0.021 | -0.582 | -0.235 | -0.396 | -0.503 | -0.382 | -3.591 |
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 10,27M | 12,7M | 16,45M | 23,86M | 27,93M | N/A | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Actions en circulation | N/A | N/A | 1,62M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 5,5M |
Ratio cours/bénéfice | -0,34 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 11,46 |
Ratio prix/valeur comptable | -1,43 |
Rendement de dividende | - |
Actions en circulation | 57,49M |
Volume moyen (1 semaine) | 12,07M |
Volume moyen (1 mois) | 35,87M |
Variation sur 52 semaines | -99,62% |
Plus haut sur 52 semaines | 29,00 |
Plus bas sur 52 semaines | 0,0955 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales